0000950123-20-001644.txt : 20200212 0000950123-20-001644.hdr.sgml : 20200212 20200212170123 ACCESSION NUMBER: 0000950123-20-001644 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200212 DATE AS OF CHANGE: 20200212 EFFECTIVENESS DATE: 20200212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Polaris Venture Management Co. V, L.L.C. CENTRAL INDEX KEY: 0001439589 IRS NUMBER: 204234752 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16125 FILM NUMBER: 20605185 BUSINESS ADDRESS: STREET 1: ONE MARINA PARK DRIVE STREET 2: 10TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 781-290-0770 MAIL ADDRESS: STREET 1: ONE MARINA PARK DRIVE STREET 2: 10TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001439589 XXXXXXXX 12-31-2019 12-31-2019 Polaris Venture Management Co. V, L.L.C.

One Marina Park Drive 10th Floor Boston MA 02210

13F HOLDINGS REPORT 028-16125 N Lauren Crockett 855-787-3500 /s/ Lauren Crockett Boston MA 02-12-2020 0 11 137489 false INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F Atyr Pharma Inc. Common Stock 002120103 544 130571 SH SOLE 130571 0 0 Cardlytics, Inc. Common Stock 14161W105 12572 200000 SH SOLE 200000 0 0 Dare Bioscience, Inc. Common Stock 23666P101 268 326243 SH SOLE 326243 0 0 Fate Therapeutics, Inc. Common Stock 31189P102 22306 1139783 SH SOLE 1139783 0 0 Genocea Biosciences, Inc. Common Stock 372427401 509 246078 SH SOLE 246078 0 0 Kala Pharmaceuticals, Inc. Common Stock 483119103 2086 565289 SH SOLE 565289 0 0 Neuronetics, Inc. Common Stock 64131A105 3289 732583 SH SOLE 732583 0 0 Phreesia, Inc. Common Stock 71948P106 85623 3214092 SH SOLE 3214092 0 0 Pulmatrix, Inc. Common Stock 74584P202 309 359439 SH SOLE 359439 0 0 Selecta Biosciences, Inc. Common Stock 816212104 6650 2773479 SH SOLE 2773479 0 0 x4 Pharmaceuticals Inc. Common Stock 98420x103 3333 311492 SH SOLE 311492 0 0